AUTH/3710/11/22 - Complainant v Merck Sharp & Dohme
Alleged promotion of pembrolizumab on LinkedIn
-
Received21 November 2022
-
Case numberAUTH/3710/11/22
-
StatusBreach ruled, case report pending